USFDA completes cGMP inspection at Cipla’s Goa facility

30 Sep 2019 Evaluate

United States Food and Drug Administration (USFDA) has completed a cGMP inspection at Cipla’s Goa manufacturing facility. The inspection was conducted from September 16 to September 27, 2019. The inspection ended with 12 observations, none of which are related to data integrity.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.

Cipla Share Price

1347.65 -10.15 (-0.75%)
27-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1738.10
Dr. Reddys Lab 1287.20
Cipla 1347.65
Zydus Lifesciences 922.50
Lupin 2301.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×